Hope S Rugo

Hope S Rugo

UNVERIFIED PROFILE

Are you Hope S Rugo?   Register this Author

Register author
Hope S Rugo

Hope S Rugo

Publications by authors named "Hope S Rugo"

Are you Hope S Rugo?   Register this Author

100Publications

1720Reads

44Profile Views

Using diagnosis codes in claims data to identify cohorts of breast cancer patients following initial treatment.

Breast J 2020 Jul 20;26(7):1472-1474. Epub 2020 Jan 20.

Philip R. Lee Institute for Health Policy Studies, Center for Healthcare Value, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13758DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369243PMC
July 2020

The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review.

Adv Ther 2020 Jul 22;37(7):3059-3082. Epub 2020 May 22.

Institut de Cancérologie de Strasbourg, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-020-01379-xDOI Listing
July 2020

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.

JAMA Oncol 2020 Jul 23. Epub 2020 Jul 23.

Berry Consultants, LLC, Austin, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2020.2535DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378873PMC
July 2020

Identifying tests related to breast cancer care in claims data.

Breast J 2020 Jun 18;26(6):1227-1230. Epub 2019 Nov 18.

Philip R. Lee Institute for Health Policy Studies, Center for Healthcare Value, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13691DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304302PMC
June 2020

Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology.

Am Soc Clin Oncol Educ Book 2020 May;40:e292-e308

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_280845DOI Listing
May 2020

Prognostic Value of Plasma HER2 Gene Copy Number in HER2-Positive Metastatic Breast Cancer Treated with First-Line Trastuzumab.

Onco Targets Ther 2020 19;13:4385-4395. Epub 2020 May 19.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital and Institute, Beijing 100142, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S240990DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245474PMC
May 2020

Understanding the Role of Comparative Clinical Studies in the Development of Oncology Biosimilars.

J Clin Oncol 2020 Apr 14;38(10):1070-1080. Epub 2020 Feb 14.

University of California, San Francisco, Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.02953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106981PMC
April 2020

Methylome Variation Predicts Exemestane Resistance in Advanced ER Breast Cancer.

Technol Cancer Res Treat 2020 Jan-Dec;19:1533033819896331

Department of Breast Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1533033819896331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057408PMC
March 2020

MYC Dysregulates Mitosis, Revealing Cancer Vulnerabilities.

Cell Rep 2020 Mar;30(10):3368-3382.e7

Department of Cell & Tissue Biology, University of California, San Francisco, San Francisco, CA, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2020.02.041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085414PMC
March 2020

Highlights from the 2019 San Antonio Breast Cancer Symposium.

Authors:
Hope S Rugo

Clin Adv Hematol Oncol 2020 Mar;18(3):157-159

View Article

Download full-text PDF

Source
March 2020

Fitbit Usage in Patients With Breast Cancer Undergoing Chemotherapy.

Clin Breast Cancer 2019 12 25;19(6):443-449.e1. Epub 2019 May 25.

University of California, San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2019.05.005DOI Listing
December 2019

Androgen receptor gene expression in primary breast cancer.

NPJ Breast Cancer 2019 10;5:47. Epub 2019 Dec 10.

3University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-019-0142-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904475PMC
December 2019

Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes.

JNCI Cancer Spectr 2019 Dec 1;3(4):pkz058. Epub 2019 Aug 1.

Department of Biostatistics, Harvard University, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pkz058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050006PMC
December 2019

Treatment of early-stage hormone receptor-positive breast cancer.

Authors:
Hope S Rugo

Clin Adv Hematol Oncol 2019 Nov;17(11):596-599

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

View Article

Download full-text PDF

Source
November 2019

Cyclin-dependent kinase 4/6 inhibition in the treatment of hormone receptor-positive breast cancer.

Authors:
Hope S Rugo

Clin Adv Hematol Oncol 2019 10;17(10):555-558

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

View Article

Download full-text PDF

Source
October 2019

Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease.

Breast Cancer Res Treat 2019 Sep 6;177(2):401-408. Epub 2019 Jun 6.

Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05309-6DOI Listing
September 2019

Phosphoinositide 3-kinase inhibition in the treatment of hormone receptor-positive breast cancer.

Authors:
Hope S Rugo

Clin Adv Hematol Oncol 2019 Sep;17(9):486-489

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

View Article

Download full-text PDF

Source
September 2019

Achieving Improved Survival Outcomes in Advanced Breast Cancer.

Authors:
Hope S Rugo

N Engl J Med 2019 07;381(4):371-372

From the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1906236DOI Listing
July 2019

A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel.

NPJ Breast Cancer 2019 14;5:17. Epub 2019 Jun 14.

1Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-019-0112-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570645PMC
June 2019

The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea.

Breast Cancer Res Treat 2019 May 22;175(1):5-15. Epub 2019 Jan 22.

City of Hope Medical Group, Inc, 1500 E Duarte Rd, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05102-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491395PMC
May 2019

Alpelisib for -Mutated, Hormone Receptor-Positive Advanced Breast Cancer.

N Engl J Med 2019 05;380(20):1929-1940

From Institut Gustave Roussy, INSERM Unité 981, Université Paris-Sud, Villejuif (F.A.), Institut de Cancérologie de l'Ouest, St. Herblain (M.C.), and Novartis Pharma, Paris (A.-S.L.) - all in France; Hospital Universitario 12 de Octubre, Madrid (E.C.); National Institute of Oncology (G.R.) and Duna Medical Center (Z.P.), Budapest, Hungary; German Breast Group, Neu-Isenburg, and Center for Hematology and Oncology Bethanien, Frankfurt - both in Germany (S.L.); UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.); Aichi Cancer Center, Nagoya (H.I.), Kanagawa Cancer Center, Yokohama (T.Y.), Saitama Cancer Center, Saitama (K.I.), and National Hospital Organization Hokkaido Cancer Center, Sapporo (M.T.) - all in Japan; Istituto Oncologico Veneto and the Departments of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy (P.C.); Vanderbilt University, Nashville (I.A.M.); Chaim Sheba Medical Center, Tel Hashomer, Israel (B.K.); National Taiwan University Hospital, Taipei (Y.-S.L.); Novartis Pharma, Basel, Switzerland (D.M., C.W.); Novartis Pharmaceuticals, East Hanover, NJ (S.H.); and Massachusetts General Hospital Cancer Center, Boston (D.J.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1813904
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1813904DOI Listing
May 2019

Demystifying biosimilars: development, regulation and clinical use.

Future Oncol 2019 Mar 30;15(7):777-790. Epub 2018 Nov 30.

Pfizer, Maidenhead, UK.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon-2018-0680
Publisher Site
http://dx.doi.org/10.2217/fon-2018-0680DOI Listing
March 2019

Advance Care Planning in Community: An Evaluation of a Pilot 2-Session, Nurse-Led Workshop.

Am J Hosp Palliat Care 2019 Feb 28;36(2):143-146. Epub 2018 Aug 28.

4 Division of Hematology and Oncology, Department of Medicine, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1049909118797612
Publisher Site
http://dx.doi.org/10.1177/1049909118797612DOI Listing
February 2019

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.

N Engl J Med 2019 02;380(8):741-751

From the Massachusetts General Hospital Cancer Center (A.B., S.J.I.) and Dana-Farber Cancer Institute (S.M.T.), Harvard Medical School, Boston; Vanderbilt-Ingram Cancer Center, Nashville (I.A.M., V.G.A.); Weill Cornell Medical College (L.T.V.) and New York-Presbyterian-Columbia University Irving Medical Center (K.K.), New York; University of Colorado Cancer Center, Aurora (J.R.D.); Texas Oncology, Baylor University Medical Center, US Oncology, Dallas (J.O.); Orlando Health University of Florida Health Cancer Center, Orlando (R.L.M., N.C.S.); Yale University School of Medicine, New Haven, CT (A.D.S.); University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.); Immunomedics, Morris Plains, NJ (D.M.G., R.I., S.W., R.M.S., W.A.W.); and AIS Consulting, Ann Arbor, MI (A.M.S.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1814213
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1814213DOI Listing
February 2019

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

N Engl J Med 2018 11 20;379(22):2108-2121. Epub 2018 Oct 20.

From the Barts Cancer Institute, Queen Mary University of London, London (P.S.); Perlmutter Cancer Center, New York University School of Medicine, New York (S.A.); the Department of Medicine, University of California, San Francisco, San Francisco (H.S.R.), and Genentech, South San Francisco (L.M., S.Y.C., R.F.) - both in California; University Hospital Heidelberg, Heidelberg, Germany (A.S.); Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre (C.H.B.), and the University of São Paulo, São Paulo (R.H.) - both in Brazil; Aichi Cancer Center Hospital, Nagoya, Japan (H.I.); the Department of Medical Oncology, Institut Curie, Paris (V.D.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Florida Cancer Specialists and Research Institute, New Port Richey (G.S.W.); Roche, Basel, Switzerland (V.H., A.H.); Dana-Farber Cancer Institute, Boston (E.P.W.); Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S.L.); and the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore (L.A.E.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1809615
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1809615DOI Listing
November 2018

The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopecia.

Future Oncol 2018 Oct 12;14(24):2461-2469. Epub 2018 Jul 12.

Helen Diller Family Comprehensive Center, University of California, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon-2018-0178
Publisher Site
http://dx.doi.org/10.2217/fon-2018-0178DOI Listing
October 2018

Circulating Tumors Cells as a Biomarker of Radiation Benefit.

JAMA Oncol 2018 08 9;4(8):e180194. Epub 2018 Aug 9.

University of California, San Francisco, Comprehensive Cancer Center, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.0194DOI Listing
August 2018

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.

N Engl J Med 2018 08 15;379(8):753-763. Epub 2018 Aug 15.

From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California; the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany; Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France; Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.); and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1802905DOI Listing
August 2018

Highlights in breast cancer from the 2018 American Society of Clinical Oncology annual meeting.

Authors:
Hope S Rugo

Clin Adv Hematol Oncol 2018 Aug;16(8):533-537

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

View Article

Download full-text PDF

Source
August 2018

Strategies and Progress of Endocrine Therapy for Patients with Metastatic Breast Cancer.

Adv Exp Med Biol 2017 ;1026:403-418

Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University, Cancer Hospital & Institute, Beijing, 100142, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-981-10-6020-5_19DOI Listing
July 2018

The new world of biosimilars in oncology: Translation of data to the clinic.

Eur J Cancer 2018 06 18;96:125-127. Epub 2018 Apr 18.

Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology, Barcelona, Spain; IOB Institute of Oncology, Quiron Group, Madrid & Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.03.005DOI Listing
June 2018

Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer.

Chin J Cancer Res 2018 Jun;30(3):315-326

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21147/j.issn.1000-9604.2018.03.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037585PMC
June 2018

Phosphatidylinositol 3-Kinase α-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study.

J Clin Oncol 2018 05 5;36(13):1291-1299. Epub 2018 Feb 5.

Dejan Juric, Massachusetts General Hospital Cancer Center, Boston; Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; Jordi Rodon and Josep Tabernero, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona; Marta Gil-Martin, Catalan Institute of Oncology - Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain; Filip Janku, The University of Texas MD Anderson Cancer Center, Houston, TX; Howard A. Burris, Sarah Cannon Research Institute and Tennessee Oncology; Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN; Jan H.M. Schellens, Netherlands Cancer Institute, Amsterdam, the Netherlands; Mark R. Middleton, National Institute for Health Research, Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom; Martin Schuler, West German Cancer Center, University Duisburg-Essen, and German Cancer Consortium, Partner Site University Hospital Essen, Essen; Ruth Seggewiss-Bernhardt, Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany; Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Douglas Bootle, David Demanse, Lars Blumenstein, and Cornelia Quadt, Novartis Pharma AG, Basel, Switzerland; Christina Coughlin, Novartis Pharmaceuticals Corporation, East Hanover, NJ; and José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.72.7107
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.72.7107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920739PMC
May 2018

Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Clin Breast Cancer 2018 02 10;18(1):19-28. Epub 2017 Aug 10.

Medical Device Consultants of Ridgewood LLC, Ridgewood, NJ. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.07.012DOI Listing
February 2018

Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.

Breast Cancer Res Treat 2018 01 18;167(1):117-122. Epub 2017 Sep 18.

Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, San Francisco, CA, 94115, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4506-z
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4506-zDOI Listing
January 2018

Emerging data on improving response to hormone therapy: the role of novel targeted agents.

Expert Rev Anticancer Ther 2018 01 8;18(1):3-18. Epub 2017 Dec 8.

b Division of Hematology and Oncology , University of California San Francisco, Helen Diller Family Comprehensive Cancer Center , San Francisco , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1412259DOI Listing
January 2018

TIM-3 Regulates CD103 Dendritic Cell Function and Response to Chemotherapy in Breast Cancer.

Cancer Cell 2018 01;33(1):60-74.e6

Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive SRB-2, Tampa, FL 33612, USA; Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.11.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764109PMC
January 2018

Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial.

J Clin Oncol 2017 Dec 2;35(36):4035-4041. Epub 2017 Nov 2.

Jean-Sebastien Frenel, Institut de Cancerologie de l'Ouest, Centre René Gauducheau, Saint-Herblain; Christophe Le Tourneau, Institut Curie, Paris and Saint-Cloud, and Institut National de la Santé et de la Recherche Médicale U900 Research Unit, Saint-Cloud; Carlos Gomez-Roca, Institut Claudius Regaud, Toulouse; Andrea Varga, Gustave Roussy, Villejuif, France; Bert O'Neil, Indiana University Health University Hospital, Indianapolis, IN; Patrick A. Ott, Dana-Farber Cancer Institute, Boston, MA; Sarina A. Piha-Paul, The University of Texas MD Anderson Cancer Center, Houston, TX; Emilie M.J. van Brummelen, The Netherlands Cancer Institute, Amsterdam, Netherlands; Hope S. Rugo, University of California, San Francisco, San Francisco, CA; and Shari Thomas, Sanatan Saraf, and Reshma Rangwala, Merck & Co., Inc., Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.5471DOI Listing
December 2017

Real-world use of scalp cooling to reduce chemotherapy-related hair loss.

Authors:
Hope S Rugo

Clin Adv Hematol Oncol 2017 Nov;15(11):828-831

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

View Article

Download full-text PDF

Source
November 2017

Dual HER2 Blockade.

Breast Care (Basel) 2017 Oct 30;12(5):345-349. Epub 2017 Oct 30.

Gynecology Clinic, HELIOS Hospital Berlin Buch, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000484226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704717PMC
October 2017

Highlights in breast cancer from the 2017 American Society of Clinical Oncology Annual Meeting.

Authors:
Hope S Rugo

Clin Adv Hematol Oncol 2017 Aug;15(8):607-614

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

View Article

Download full-text PDF

Source
August 2017